Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1625, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Maraviroc makes a difference for R5 HIV-1 infections
Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. :
Access to resources
Recommend
Maraviroc: a guide to its use in HIV-1 infection
Drugs & Therapy Perspectives, Vol. 24, Iss. 3, 2008-03 ,pp. :
Maraviroc MOTIVATEs virological response in HIV-1-infected patients
Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. :
The CCR5 receptor antagonist maraviroc reduces viral load in patients with HIV-1 infection
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
Maraviroc: A Review of its Use in the Management of CCR5-Tropic HIV-1 Infection
Drugs, Vol. 70, Iss. 9, 2010-06 ,pp. :